<unk>  is produced by removal of the trivalent iron moiety from ferrioxamine B, an iron-bearing sideramine produced by the actinomycetes, Streptomyces pilosus. Its discovery was a serendipitous result of research conducted by scientists at Ciba in collaboration with scientists at the Swiss Federal Institute of Technology in Zurich and the University Hospital in Freiburg, Germany<unk>  acts by binding free iron in the bloodstream and enhancing its elimination in the urine. By removing excess iron from persons with hemochromatosis, the agent reduces the damage done to various organs and tissues, such as the liver. Also, it speeds healing of nerve damage (and minimizes the extent of recent nerve trauma).<unk>  may modulate expression and release of inflammatory mediators by specific cell types.
Deferoxamine
Dimercaprol
Mercapturic acid
Sodium thiosulfate 
Disufenton sodium
Dimercaptosuccinic acid
Alphos
Fomepizole